Keywords: strong, data, merck, co, sitagliptin, plus, metformin

Strong data for Merck & Co's sitagliptin plus metformin

Article | 24 September 2007

Print This

The UK unit of US drug major Merck & Co says that new, one-year clinical trial data show that initial combination ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in